About Neximmune (NEXI)
NexImmune, Inc is a clinical-stage biotechnology company. The Company is engaged in developing a novel approach to immunotherapy designed to employ the body’s own T cells to generate an immune response that mimics natural biology. The Company provide... Read more
- USD3.35
- USD3.35
- USD3.15
- USD28.69
- -40.10%
- --
- 10.54k
- 37.61k
- 5M
- 1.25
- -62.80%
Stock News
3 hours ago
Q1 2024 Gibraltar Industries Inc Earnings Call
Yahoo
5 hours ago
BlackRock, Citadel Reap Billion-Dollar Deals From Australia Fund
Yahoo
6 hours ago
Here's What Key Metrics Tell Us About Beazer (BZH) Q2 Earnings
Yahoo
6 hours ago
American Financial (AFG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
